Abstract
In July 1997, the first European clinical trial on BNCT (EORTC 11961) was officially opened. The first patient was subsequently treated soon after in October. The treatment takes place at the High Flux Reactor (HFR) at Petten in The Netherlands.1 The approach to treat a patient at a nuclear research reactor requires a complex organisational structure, which is further exacerbated by the involvement of technical staff unaccustomed to dealing with patients, as well as working alongside clinicians.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.L. Moss, J. Casado, K. Ravensberg, F. Stecher-Rasmussen, and P. Watkins, “The Completed BNCT Facility at the HFR Petten”, in Proc. 7th Int. Symp. on Neutron Capture Therapy, Zurich, September 1996; Ed. B. Larsson, J. Crawford, Plenum Press, New York, 1997.
W. Sauerwein, R. Moss, K. Hideghéty, F. Stecher-Rasmussen, M. de Vries, H.-J. Reulen, C. Götz, P. Pacquis, F. Grochulla, K. Haselsberger, J. Wolbers, J. Rassow, J.P. Pignol, P. Watkins, C. Vroegindeweij, K. Ravensberg, S. Garbe, O.D. Wiestler, B. Turowski, F. Zanella, D. Touw, A. Siefert, R. Huiskamp, H. Fankhauser, and D. Gabel, “Status Report on the European Clinical Trial of BNCT at Petten”, Report on the first group of patients in the European phase I trial (EORTC Protocol 11961) at the High Flux Reactor in Petten”, these proceedings.
K. Hideghéty, W. Sauerwein, M. de Vries, F. Grochulla, C. Goetz, K. Haselsberger, P. Pacquis, J. Wolbers, J. Heimans, R. Huiskamp, R. Moss, D. Gabel, and H. Fankhauser, “Report on the first group of patients in the European phase I trial (EORTC Protocol 11961) at the High Flux eactor in Petten”, these proceedings.
Good Clinical Practice for Trials on Medicinal Products in the European Community, for Proprietary Medicinal Products [CPMP] EEC 111/3976/88-EN, July 1990.
CMP Working Party on Efficiency of Medical Products, EEC Note for Guidance: Good clinical practice for trials on medical products in the European Community. Pharmacology & Toxicology 1990, 67, 361-372.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moss, R.L., Stecher-Rasmussen, F., Sauerwein, W., Gabel, D., Watkins, P., Vroegindeweij, C. (2001). Standard Operating Procedures Followed by the Petten BNC-Team during Patient Treatment. In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_31
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive